The DOI matches its Crossref record; 273 of the 273 references it cites were found in a registry or an index.
Hypoxia and brain aging: Neurodegeneration or neuroprotection?
Open accessAbstract
The absolute reliance of the mammalian brain on oxygen to generate ATP renders it acutely vulnerable to hypoxia, whether at high altitude or in clinical settings of anemia or pulmonary disease. Hypoxia is pivotal to the pathogeneses of myriad neurological disorders, including Alzheimer's, Parkinson's and other age-related neurodegenerative diseases. Conversely, reduced environmental oxygen, e.g. sojourns or residing at high altitudes, may impart favorable effects on aging and mortality. Moreover, controlled hypoxia exposure may represent a treatment strategy for age-related neurological disorders. This review discusses evidence of hypoxia's beneficial vs. detrimental impacts on the aging brain and the molecular mechanisms that mediate these divergent effects. It draws upon an extensive literature search on the effects of hypoxia/altitude on brain aging, and detailed analysis of all identified studies directly comparing brain responses to hypoxia in young vs. aged humans or rodents. Special attention is directed toward the risks vs. benefits of hypoxia exposure to the elderly, and potential therapeutic applications of hypoxia for neurodegenerative diseases. Finally, important questions for future research are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Serebrovska, Z. O., Serebrovskaya, T. V., Kholin, V. A., Tumanovska, L. V., Shysh, A. M., Pashevin, D. O., Goncharov, S. V., Stroy, D., Grib, O. M., Shatylo, V. B., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215405 · Cited by 115
RetractedCai, X., Li, X., Jin, S., Liang, D., Wen, Z., Cao, H., Mei, H., Wu, Y., Lin, Z., & Wang, L. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.029 · Cited by 88
RetractedEl-Ghaiesh, S. H., Bahr, H. I., Ibrahiem, A. T., Ghorab, D. S., Alomar, S. Y., Farag, N. E., & Zaitone, S. A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00084 · Cited by 69
RetractedAging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“The finding that aggregated α-synuclein is a major component of Lewy bodies and Lewy neurites, the proteopathic hallmarks of Parkinson’s disease, confirmed α-synuclein aggregation as a central pathogenic event (Spillantini et al., 1997).”
BackgroundAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“The amyloid cascade hypothesis (Hardy and Higgins, 1992; Hardy, 2017) is the leading model of Alzheimer’s disease pathogenesis.”
BackgroundMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“dysfunction (Beal, 2005; Lin and Beal, 2006) have been implicated in “normal” aging, too.”
BackgroundInflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Sies, H., & Jones, D. P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0230-3 · Cited by 5,335 · cited 9×
“While hypoxia activates HIF, Nrf2 is activated by ROS generated upon reoxygenation.”
BackgroundInfluentialAmyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Kenyon, C. J. (2010) · Nature · doi:10.1038/nature08980 · Cited by 2,739
Eltzschig, H. K., & Carmeliet, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0910283 · Cited by 2,061 · cited 1×
“Hypoxia can either provoke or suppress oxidative stress, mitochondrial dysfunction (Hwang and Lee, 2011) and inflammation (Eltzschig and Carmeliet, 2011) and the HIF pathway is crucially involved, suggesting hypoxia conditioning could potentially modulate brain aging (Mallet et al.”
BackgroundHow neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967 · cited 2×
“The major pathogenetic mechanisms of neurodegeneration, including neuroinflammation (Ransohoff, 2016), oxidative stress and mitochondrial dysfunction (Beal, 2005; Lin and Beal, 2006) have been implicated in “normal” aging, too.”
BackgroundOxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954 · cited 1×
“, 2017), oxidative stress and glucose metabolism (Butterfield and Halliwell, 2019) and the emergent role of the non-neuronal cells in”
BackgroundRegulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · cited 2×
“…by signaling molecules, primarily reactive O2 species, i.e. ROS (Sies and Jones, 2020) and transcription factors, such as hypoxia inducible factors (HIFs), the central regulators of O2 homeostasis (Semenza, 1999), and nuclear factor erythroid 2-related factor 2 (Nrf2) (Leonard et al., 2006).”
BackgroundReducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · cited 1×
“Both aging and CIH-challenged younger mice displayed hyperactivity in the Y-maze test, a behavioral hallmark of genetically modified mice modeling Alzheimer’s disease (Roberson et al., 2007).”
BackgroundThe many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
Baird, L., & Yamamoto, M. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00099-20 · Cited by 1,542
Hackett, P. H., & Roach, R. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107123450206 · Cited by 1,302
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291 · cited 1×
“It also lowers several cardiovascular risk factors of Alzheimer’s disease and other neurodegenerative diseases, namely obesity, hypertension, metabolic syndrome and ischemia (Kivipelto et al., 2005; Navarrete-Opazo and Mitchell, 2014).”
BackgroundCellular Adaptation to Hypoxia through Hypoxia Inducible Factors and beyond
Lee, P., Chandel, N. S., & Simon, M. C. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0227-y · Cited by 1,272 · cited 1×
“Van Hippel-Lindau proteins (VHL) interact with the hydroxylated α-subunits, facilitating their poly-ubiquitinylation, which targets them for degradation by 26 s proteasomes (Kaelin and Ratcliffe, 2008; Lee et al., 2020; Lendahl et al., 2009).”
BackgroundObstructive sleep apnoea syndrome
Lévy, P., Kohler, M., McNicholas, W. T., Barbé, F., McEvoy, R. D., Somers, V. K., Lavie, L., & Pépin, J.-L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.15 · Cited by 1,235
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Soto, C., & Pritzkow, S. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0235-9 · Cited by 1,180 · cited 1×
“A common phenomenon among diverse neurodegenerative diseases is the occurrence of proteinaceous intra- or extracellular inclusions (Soto and Pritzkow, 2018).”
BackgroundOxygen sensing and molecular adaptation to hypoxia
Bunn, H. F., & Poyton, R. O. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.839 · Cited by 1,172
Parkinson’s disease: etiopathogenesis and treatment
Jankovic, J., & Tan, E. K. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322338 · Cited by 1,169
Yaffe, K., Laffan, A. M., Harrison, S. L., Redline, S., Spira, A. P., Ensrud, K. E., Ancoli-Israel, S., & Stone, K. L. (2011) · JAMA · doi:10.1001/jama.2011.1115 · Cited by 1,137
Hochachka, P. W., Buck, L. T., Doll, C. J., & Land, S. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9493 · Cited by 1,105
Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease
KIDD, M. (1963) · Nature · doi:10.1038/197192b0 · Cited by 1,012 · cited 4×
“The most common form of dementia, Alzheimer’s disease, is char- acterized by intracellular deposition of neurofibrillary tangles (Kidd, 1963) mainly composed of hyperphosphorylated tau protein (Grundke-Iqbal et al., 1986; Kidd, 1963; Grundke-Iqbal et al., 1986) and extracellular deposition of…”
BackgroundInfluentialFranceschi, C., Garagnani, P., Vitale, G., Capri, M., & Salvioli, S. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.09.005 · Cited by 997
Obstructive sleep apnoea syndrome – an oxidative stress disorder
Lavie, L. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0261 · Cited by 993 · cited 2×
“resultant oxidative damage of biomolecules (Lavie, 2003), mitochondrial dysfunction (Duranteau et al.”
BackgroundA systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity
Lee, S. S., Lee, R. Y. N., Fraser, A. G., Kamath, R. S., Ahringer, J., & Ruvkun, G. (2003) · Nature Genetics · doi:10.1038/ng1056 · Cited by 969 · cited 2×
“…also prolong the viability of cultured cells (Packer and Fuehr, 1977), and lifespan of Caenorabditis elegans (Feng et al., 2001; Kayser et al., 2004; Lee et al., 2003; Mehta et al., 2009), Drosophila melanogaster (Copeland et al., 2009) and mice (Dell’agnello et al., 2007; Lapointe and Hekimi,…”
BackgroundMitochondria take center stage in aging and neurodegeneration
Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20624 · Cited by 957
Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
Reeve, A., Simcox, E., & Turnbull, D. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.004 · Cited by 947
Mitochondria and neuronal activity
Kann, O., & Kovács, R. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00222.2006 · Cited by 855
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808
Regulation of erythropoiesis by hypoxia-inducible factors
Haase, V. H. (2013) · Blood Reviews · doi:10.1016/j.blre.2012.12.003 · Cited by 787
Yang, J., Huang, T., Petralia, F., Long, Q., Zhang, B., Argmann, C., Zhao, Y., Mobbs, C. V., Schadt, E. E., Zhu, J., et al. (2016) · Scientific Reports · doi:10.1038/srep19384 · Cited by 720
Intracellular Signaling by Reactive Oxygen Species during Hypoxia in Cardiomyocytes
Duranteau, J., Chandel, N. S., Kulisz, A., Shao, Z., & Schumacker, P. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11619 · Cited by 679
Mitochondrial Electron Transport Is a Key Determinant of Life Span in Caenorhabditis elegans
Feng, J., Bussière, F., & Hekimi, S. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00071-5 · Cited by 672
Prabhakar, N. R., & Semenza, G. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00030.2011 · Cited by 641
Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
Zhang, M., An, C., Gao, Y., Leak, R. K., Chen, J., & Zhang, F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.09.003 · Cited by 617
Dirnagl, U., Becker, K., & Meisel, A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70054-7 · Cited by 587
Amyloid-β-independent regulators of tau pathology in Alzheimer disease
van der Kant, R., Goldstein, L. S. B., & Ossenkoppele, R. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0240-3 · Cited by 580
Mammalian Mitochondria and Aging: An Update
Kauppila, T. E. S., Kauppila, J. H. K., & Larsson, N.-G. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.017 · Cited by 578
Genome sequencing reveals insights into physiology and longevity of the naked mole rat
Kim, E. B., Fang, X., Fushan, A. A., Huang, Z., Lobanov, A. V., Han, L., Marino, S. M., Sun, X., Turanov, A. A., Yang, P., et al. (2011) · Nature · doi:10.1038/nature10533 · Cited by 576
The cerebral effects of ascent to high altitudes
Wilson, M. H., Newman, S., & Imray, C. H. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70014-6 · Cited by 525
Toth, P., Tarantini, S., Csiszar, A., & Ungvari, Z. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00581.2016 · Cited by 522
The Hypoxic Response: Huffing and HIFing
Guillemin, K., & Krasnow, M. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80176-2 · Cited by 478
Leng, Y., McEvoy, C. T., Allen, I. E., & Yaffe, K. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2180 · Cited by 476
Therapeutic potential of intermittent hypoxia: a matter of dose
Navarrete-Opazo, A., & Mitchell, G. S. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00208.2014 · Cited by 469
Nitric Oxide Signaling in Brain Function, Dysfunction, and Dementia
Steinert, J. R., Chernova, T., & Forsythe, I. D. (2010) · The Neuroscientist · doi:10.1177/1073858410366481 · Cited by 469
Synucleinopathies: Clinical and Pathological Implications
Galvin, J. E., Lee, V. M.-Y., & Trojanowski, J. Q. (2001) · Archives of Neurology · doi:10.1001/archneur.58.2.186 · Cited by 466
Hypoxia as a therapy for mitochondrial disease
Jain, I. H., Zazzeron, L., Goli, R., Alexa, K., Schatzman-Bone, S., Dhillon, H., Goldberger, O., Peng, J., Shalem, O., Sanjana, N. E., et al. (2016) · Science · doi:10.1126/science.aad9642 · Cited by 438
Dodd, J. W., Getov, S. V., & Jones, P. W. (2010) · European Respiratory Journal · doi:10.1183/09031936.00125109 · Cited by 426
Extension of Drosophila Life Span by RNAi of the Mitochondrial Respiratory Chain
Copeland, J. M., Cho, J., Lo, T., Hur, J. H., Bahadorani, S., Arabyan, T., Rabie, J., Soh, J., & Walker, D. W. (2009) · Current Biology · doi:10.1016/j.cub.2009.08.016 · Cited by 409
Kronenberg, R. S., & Drage, C. W. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107363 · Cited by 394
Low oxygen concentration extends the lifespan of cultured human diploid cells
PACKER, L., & FUEHR, K. (1977) · Nature · doi:10.1038/267423a0 · Cited by 392
The Ventilatory Response to Hypoxia in Mammals: Mechanisms, Measurement, and Analysis
Teppema, L. J., & Dahan, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00012.2009 · Cited by 381
Mitochondrial dysfunction as a cause of ageing
Trifunovic, A., & Larsson, N. ‐. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01905.x · Cited by 378
Insights into the evolution of longevity from the bowhead whale genome
Keane, M., Semeiks, J., Webb, A. E., Li, Y. I., Quesada, V., Craig, T., Madsen, L. B., van Dam, S., Brawand, D., Marques, P. I., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.008 · Cited by 375
Tello, D., Balsa, E., Acosta-Iborra, B., Fuertes-Yebra, E., Elorza, A., Ordóñez, Á., Corral-Escariz, M., Soro, I., López-Bernardo, E., Perales-Clemente, E., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.008 · Cited by 368
Bernaudin, M., Nedelec, A.-S., Divoux, D., MacKenzie, E. T., Petit, E., & Schumann-Bard, P. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200204000-00003 · Cited by 352
Ferini-Strambi, L., Baietto, C., Di Gioia, M. R., Castaldi, P., Castronovo, C., Zucconi, M., & Cappa, S. F. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00068-6 · Cited by 350
The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications
Arranz, A. M., & De Strooper, B. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30490-3 · Cited by 334
Peacock, A. J. (1998) · BMJ · doi:10.1136/bmj.317.7165.1063 · Cited by 333
Kerner, N. A., & Roose, S. P. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.01.134 · Cited by 331
Generating specificity and diversity in the transcriptional response to hypoxia
Lendahl, U., Lee, K. L., Yang, H., & Poellinger, L. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2665 · Cited by 330
Cognitive symptoms of Alzheimer’s disease: clinical management and prevention
Joe, E., & Ringman, J. M. (2019) · BMJ · doi:10.1136/bmj.l6217 · Cited by 321
Increased longevity and refractoriness to Ca2+-dependent neurodegeneration in Surf1 knockout mice
Dell'Agnello, C., Leo, S., Agostino, A., Szabadkai, G., Tiveron, C., Zulian, A., Prelle, A., Roubertoux, P., Rizzuto, R., & Zeviani, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl477 · Cited by 308
The insulin paradox: aging, proteotoxicity and neurodegeneration
Cohen, E., & Dillin, A. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2474 · Cited by 303
Invited Review: Physiological and pathophysiological responses to intermittent hypoxia
Neubauer, J. A. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.4.1593 · Cited by 302
NRF2 as a Therapeutic Target in Neurodegenerative Diseases
Brandes, M. S., & Gray, N. E. (2020) · ASN Neuro · doi:10.1177/1759091419899782 · Cited by 297
Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases
Cai, R., Zhang, Y., Simmering, J. E., Schultz, J. L., Li, Y., Fernandez-Carasa, I., Consiglio, A., Raya, A., Polgreen, P. M., Narayanan, N. S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129987 · Cited by 286
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases
Espay, A. J., Vizcarra, J. A., Marsili, L., Lang, A. E., Simon, D. K., Merola, A., Josephs, K. A., Fasano, A., Morgante, F., Savica, R., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000006926 · Cited by 274
Shaping the Nrf2-ARE-related pathways in Alzheimer’s and Parkinson’s diseases
Fão, L., Mota, S. I., & Rego, A. C. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100942 · Cited by 270
Aging of the Respiratory System: Impact on Pulmonary Function Tests and Adaptation to Exertion
Janssens, J.-P. (2005) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2005.05.004 · Cited by 262
Expression of hypoxia-inducible factor-1α in the brain of rats during chronic hypoxia
Chávez, J. C., Agani, F., Pichiule, P., & LaManna, J. C. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.5.1937 · Cited by 257
Leonard, M. O., Kieran, N. E., Howell, K., Burne, M. J., Varadarajan, R., Dhakshinamoorthy, S., Porter, A. G., O'Farrelly, C., Rabb, H., Taylor, C. T., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5097fje · Cited by 254
Sharma, R. A., Varga, A. W., Bubu, O. M., Pirraglia, E., Kam, K., Parekh, A., Wohlleber, M., Miller, M. D., Andrade, A., Lewis, C., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201704-0704oc · Cited by 245
Proteasomal Regulation of the Hypoxic Response Modulates Aging in C. elegans
Mehta, R., Steinkraus, K. A., Sutphin, G. L., Ramos, F. J., Shamieh, L. S., Huh, A., Davis, C., Chandler-Brown, D., & Kaeberlein, M. (2009) · Science · doi:10.1126/science.1173507 · Cited by 242
Acute hypoxia and hypoxic exercise induce DNA strand breaks and oxidative DNA damage in humans
MØLLER, P., LOFT, S., LUNDBY, C., & OLSEN, N. V. (2001) · The FASEB Journal · doi:10.1096/fj.00-0703com · Cited by 239
Effects of aging on ventilatory and occlusion pressure responses to hypoxia and hypercapnia.
Peterson, D. D., Pack, A. I., Silage, D. A., & Fishman, A. P. (1981) · PubMed · doi:10.1164/arrd.1981.124.4.387 · Cited by 234
Randall, J., Mörtberg, E., Provuncher, G. K., Fournier, D. R., Duffy, D. C., Rubertsson, S., Blennow, K., Zetterberg, H., & Wilson, D. H. (2013) · Resuscitation · doi:10.1016/j.resuscitation.2012.07.027 · Cited by 230
Zhu, X.-H., Yan, H.-C., Zhang, J., Qu, H.-D., Qiu, X.-S., Chen, L., Li, S.-J., Cao, X., Bean, J. C., Chen, L.-H., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6414-09.2010 · Cited by 227
A review on advances of treatment modalities for Alzheimer's disease
Se Thoe, E., Fauzi, A., Tang, Y. Q., Chamyuang, S., & Chia, A. Y. Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119129 · Cited by 219
Daulatzai, M. A. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23634 · Cited by 217
The Relationship between Obstructive Sleep Apnea and Alzheimer’s Disease
Andrade, A. G., Bubu, O. M., Varga, A. W., & Osorio, R. S. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179936 · Cited by 216 · cited 1×
“In OSA patients (Andrade et al., 2018; Daulatzai, 2012, 2013; Leng et al., 2017; Liguori et al., 2017), hypoxia-reoxygenation (Liu and Le,”
BackgroundLiguori, C., Mercuri, N. B., Izzi, F., Romigi, A., Cordella, A., Sancesario, G., & Placidi, F. (2017) · Sleep · doi:10.1093/sleep/zsx011 · Cited by 214
High altitude exposure impairs sleep patterns, mood, and cognitive functions
de Aquino Lemos, V., Antunes, H. K. M., dos Santos, R. V. T., Lira, F. S., Tufik, S., & de Mello, M. T. (2012) · Psychophysiology · doi:10.1111/j.1469-8986.2012.01411.x · Cited by 213
Hypoxic Conditioning as a New Therapeutic Modality
Vergès, S., Chacaroun, S., Godin‐Ribuot, D., & Baillieul, S. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2015.00058 · Cited by 209
Early Mitochondrial Dysfunction in Long-lived Mclk1+/- Mice
Lapointe, J., & Hekimi, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803287200 · Cited by 209
Structural and functional adaptation to hypoxia in the rat brain
LaManna, J. C., Chavez, J. C., & Pichiule, P. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.00976 · Cited by 209
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13932 · Cited by 205
Brain adaptation to chronic hypobaric hypoxia in rats
LaManna, J. C., Vendel, L. M., & Farrell, R. M. (1992) · Journal of Applied Physiology · doi:10.1152/jappl.1992.72.6.2238 · Cited by 204
Is there more to aging than mitochondrial DNA and reactive oxygen species?
Alexeyev, M. F. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07269.x · Cited by 197
Stetler, R. A., Leak, R. K., Gan, Y., Li, P., Zhang, F., Hu, X., Jing, Z., Chen, J., Zigmond, M. J., & Gao, Y. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.005 · Cited by 189
Snyder, B., Shell, B., Cunningham, J. T., & Cunningham, R. L. (2017) · Physiological Reports · doi:10.14814/phy2.13258 · Cited by 189
Increased brain capillaries in chronic hypoxia
Boero, J. A., Ascher, J., Arregui, A., Rovainen, C., & Woolsey, T. A. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.86.4.1211 · Cited by 182
Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration
Nalivaeva, N. N., Turner, A. J., & Zhuravin, I. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00825 · Cited by 181
Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.
Bannon, M. J., Poosch, M. S., Xia, Y., Goebel, D. J., Cassin, B., & Kapatos, G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7095 · Cited by 180
Amyloid β-protein and beyond: the path forward in Alzheimer’s disease
Walsh, D. M., & Selkoe, D. J. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.02.003 · Cited by 174
Rabin, J. S., Klein, H., Kirn, D. R., Schultz, A. P., Yang, H., Hampton, O. L., Jiang, S., Buckley, R. F., Viswanathan, A., Hedden, T., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.1879 · Cited by 171
Erythropoietin response to acute normobaric hypoxia in humans
Knaupp, W., Khilnani, S., Sherwood, J., Scharf, S., & Steinberg, H. (1992) · Journal of Applied Physiology · doi:10.1152/jappl.1992.73.3.837 · Cited by 169
Burtscher, M., Pachinger, O., Ehrenbourg, I., Mitterbauer, G., Faulhaber, M., Pühringer, R., & Tkatchouk, E. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.07.021 · Cited by 169
Self-citationIntermittent Hypoxia: Cause of or Therapy for Systemic Hypertension?
Serebrovskaya, T. V., Manukhina, E. B., Smith, M. L., Downey, H. F., & Mallet, R. T. (2008) · Experimental Biology and Medicine · doi:10.3181/0710-mr-267 · Cited by 168
Self-citationPeers, C., Dallas, M. L., Boycott, H. E., Scragg, J. L., Pearson, H. A., & Boyle, J. P. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05026.x · Cited by 167
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome
Ferrari, M., Jain, I. H., Goldberger, O., Rezoagli, E., Thoonen, R., Cheng, K.-H., Sosnovik, D. E., Scherrer-Crosbie, M., Mootha, V. K., & Zapol, W. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621511114 · Cited by 164
Oxygen and Ion Concentrations in Normoxic and Hypoxic Brain Cells
Silver, I., & Erecińska, M. (1998) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-4863-8_2 · Cited by 161
Regulation of haeme oxygenase‐1 for treatment of neuroinflammation and brain disorders
Syapin, P. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.342 · Cited by 161
Chronic Intermittent Hypoxia/Reoxygenation Facilitate Amyloid-β Generation in Mice
Shiota, S., Takekawa, H., Matsumoto, S.-E., Takeda, K., Nurwidya, F., Yoshioka, Y., Takahashi, F., Hattori, N., Tabira, T., Mochizuki, H., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130419 · Cited by 159
Gunstad, J., Benitez, A. M., Smith, J. L., Glickman, E., Spitznagel, M. B., Alexander, T. S., Juvancic-Heltzel, J. A., & Murray, L. K. (2008) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988708316860 · Cited by 159
Jones, S. F. (2012) · Yearbook of Pulmonary Disease · doi:10.1016/j.ypdi.2012.01.058 · Cited by 159
Hardy, J. (2017) · The FEBS Journal · doi:10.1111/febs.14004 · Cited by 153 · cited 1×
“The amyloid cascade hypothesis (Hardy and Higgins, 1992; Hardy, 2017) is the leading model of Alzheimer’s disease pathogenesis.”
BackgroundHypoxia‐inducible factors as neuroprotective agent in Alzheimer's disease
Ashok, B. S., Ajith, T. A., & Sivanesan, S. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12717 · Cited by 150
Role of Nitric Oxide in Cardiovascular Adaptation to Intermittent Hypoxia
Manukhina, E. B., Downey, H. F., & Mallet, R. T. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100401 · Cited by 149
Self-citationRybnikova, E. A., & Самойлов, М. О. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00388 · Cited by 147
Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra
Ma, S., Ciliax, B. J., Stebbins, G. T., Jaffar, S., Joyce, J. N., Cochran, E. J., Kordower, J. H., Mash, D. C., Levey, A. I., & Mufson, E. J. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990621)409:1<25::aid-cne3>3.0.co;2-e · Cited by 145
Hypoxia‐inducible factor 1: a new hope to counteract neurodegeneration?
Correia, S. C., & Moreira, P. I. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06443.x · Cited by 142
Fernandez, M. A., Klutkowski, J. A., Freret, T., & Wolfe, M. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.581165 · Cited by 136 · cited 1×
“CIH (10 min cycles between 5 % and 21 % O2, 8 h/day for 4 weeks) increased cerebrocortical content of amyloid β-42, the more neurotoxic of the amyloid β isoforms (Fernandez et al., 2014),”
BackgroundGozal, D., Row, B. W., Kheirandish, L., Liu, R., Guo, S. Z., Fan, Q., & Brittian, K. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01973.x · Cited by 132
Vannucci, R. C., Towfighi, J., & Vannucci, S. J. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71031215.x · Cited by 131
Effect of exercise on cerebral perfusion in humans at high altitude.
Imray, C., Myers, S. D., Pattinson, K., Bradwell, A., Chan, C., Harris, S., Collins, P., & Wright, A. (2005) · Journal of applied physiology · doi:10.1152/japplphysiol.00973.2004 · Cited by 130
Repetitive hypoxia extends endogenous neurovascular protection for stroke
Stowe, A. M., Altay, T., Freie, A. B., & Gidday, J. M. (2011) · Annals of Neurology · doi:10.1002/ana.22367 · Cited by 130
Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease
Sharma, V., Kaur, A., & Singh, T. G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110373 · Cited by 130
Jain, I. H., Zazzeron, L., Goldberger, O., Marutani, E., Wojtkiewicz, G. R., Ast, T., Wang, H., Schleifer, G., Степанова, А., Brepoels, K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.006 · Cited by 127
Mitochondrial Oxidative Phosphorylation Is Defective in the Long-lived Mutant clk-1
Kayser, E., Sedensky, M. M., Morgan, P. G., & Hoppel, C. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403066200 · Cited by 123
Nrf2 mitigates LRRK2- and α-synuclein–induced neurodegeneration by modulating proteostasis
Skibinski, G., Hwang, V., Ando, D. M., Daub, A. C., Lee, A. K., Ravisankar, A., Modan, S., Finucane, M. M., Shaby, B. A., & Finkbeiner, S. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522872114 · Cited by 123
Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders
Vasconcelos, A. R., dos Santos, N. B., Scavone, C., & Munhoz, C. D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00033 · Cited by 123
Sapin, E., Peyron, C., Roche, F., Gay, N., Carcenac, C., Savasta, M., Levy, P. A., & Demattéis, M. (2015) · SLEEP · doi:10.5665/sleep.5042 · Cited by 122
Death by a Thousand Cuts in Alzheimer’s Disease: Hypoxia—The Prodrome
Daulatzai, M. A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9379-2 · Cited by 121
Serum amyloid-beta levels are increased in patients with obstructive sleep apnea syndrome
Bu, X., Liu, Y.-H., Wang, Q., Jiao, S., Zeng, F., Yao, X., Gao, D., Chen, J., & Wang, Y. (2015) · Scientific Reports · doi:10.1038/srep13917 · Cited by 120
Extreme Terrestrial Environments: Life in Thermal Stress and Hypoxia. A Narrative Review
Burtscher, M., Gatterer, H., Burtscher, J., & Mairbäurl, H. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00572 · Cited by 120
Self-citationRegulation of life span by mitochondrial respiration: the HIF-1 and ROS connection
Hwang, A. B., & Lee, S. (2011) · Aging · doi:10.18632/aging.100292 · Cited by 117
Intermittent hypoxic–hyperoxic training on cognitive performance in geriatric patients
Bayer, U., Likar, R., Pinter, G., Stettner, H. M., Demschar, S., Trummer, B., Neuwersch-Sommeregger, S., Glazachev, O. S., & Burtscher, M. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.01.002 · Cited by 117
Self-citationLactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice
Xu, S.-F., Zhang, Y.-H., Wang, S., Pang, Z.-Q., Fan, Y.-G., Li, J., Zhan-you, W., & Guo, C. (2018) · Redox Biology · doi:10.1016/j.redox.2018.101090 · Cited by 117
Humans In Hypoxia: A Conspiracy Of Maladaptation?!
Dempsey, J. A., & Morgan, B. J. (2015) · Physiology · doi:10.1152/physiol.00007.2015 · Cited by 115
Prolonged anoxic survival due to anoxia pre-exposure: brain ATP, lactate, and pyruvate
Dahl, N. A., & Balfour, W. M. (1964) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1964.207.2.452 · Cited by 114
Haider, T., Casucci, G., Linser, T., Faulhaber, M., Gatterer, H., Ott, G., Linser, A., Ehrenbourg, I., Tkatchouk, E. N., Burtscher, M., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832c0018 · Cited by 113
Self-citationHIF‐1 modulates longevity and healthspan in a temperature‐dependent manner
Leiser, S. F., Begun, A., & Kaeberlein, M. R. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00672.x · Cited by 112
The function of hypoxia‐inducible factor 1 (HIF‐1) is impaired in senescent mice
Frenkel-Denkberg, G., Gershon, D., & Levy, A. P. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01552-5 · Cited by 109
Poststroke Induction of -Synuclein Mediates Ischemic Brain Damage
Kim, T., Mehta, S. L., Kaimal, B., Lyons, K. E., Dempsey, R. J., & Vemuganti, R. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1241-16.2016 · Cited by 109
Beaudin, A. E., Waltz, X., Hanly, P. J., & Poulin, M. J. (2017) · Experimental Physiology · doi:10.1113/ep086051 · Cited by 109
Xie, H., Leung, K.-L., Chen, L., Chan, Y., Ng, P.-C., Fok, T. F., Wing, Y. K., Ke, Y., Li, A. M., & Yung, W. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.020 · Cited by 108
Fisk, L., Nalivaeva, N. N., Boyle, J. P., Peers, C., & Turner, A. J. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9349-2 · Cited by 107
Lourenço, C. F., Ledo, A., Barbosa, R. M., & Laranjinha, J. A. N. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.026 · Cited by 107
Intermittent Hypoxia Training for Treating Mild Cognitive Impairment: A Pilot Study
Wang, H., Shi, X., Schenck, H., Hall, J. R., Ross, S. E., Kline, G. P., Chen, S., Mallet, R. T., & Chen, P. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317519896725 · Cited by 103
Self-citationEffect of intermittent normobaric hypoxia on aerobic capacity and cognitive function in older people
Schega, L., Peter, B., Brigadski, T., Leßmann, V., Isermann, B., Hamacher, D., & Törpel, A. (2016) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2016.02.012 · Cited by 100
Baillieul, S., Chacaroun, S., Doutreleau, S., Detante, O., Pépin, J., & Vergès, S. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217712691 · Cited by 99
Cognition at Altitude: Impairment in Executive and Memory Processes Under Hypoxic Conditions
Asmaro, D., Mayall, J., & Ferguson, S. (2013) · Aviation Space and Environmental Medicine · doi:10.3357/asem.3661.2013 · Cited by 96
Schega, L., Peter, B., Törpel, A., Mutschler, H., Isermann, B., & Hamacher, D. (2013) · Gerontology · doi:10.1159/000350927 · Cited by 94
Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease
Manukhina, E. B., Downey, H. F., Shi, X., & Mallet, R. T. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216649060 · Cited by 94
Self-citationMillet, G. P., & Debevec, T. (2020) · The Journal of Physiology · doi:10.1113/jp278673 · Cited by 93
Self-citationGuo, C., Hao, L.-J., Yang, Z., Chai, R., Zhang, S., Gu, Y., Gao, H., Zhong, M., Wang, T., Li, J., et al. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.03.016 · Cited by 92
The hypoxia-inducible factor HIF-1 functions as both a positive and negative modulator of aging
Leiser, S. F., & Kaeberlein, M. R. (2010) · Biological Chemistry · doi:10.1515/bc.2010.123 · Cited by 88
Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction
Raz, L., Bhaskar, K., Weaver, J., Marini, S., Zhang, Q., Thompson, J. F., Espinoza, C., Iqbal, S., Maphis, N. M., Weston, L., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.009 · Cited by 84 · cited 1×
“In rats (Raz et al., 2019), and in wild-type (Yagishita et al.”
BackgroundBlood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly
Glodzik, L., Rusinek, H., Pirraglia, E., McHugh, P. F., Tsui, W., Williams, S., Cummings, M., Li, Y., Rich, K. E., Randall, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.011 · Cited by 82
Gao, L., Tian, S., Gao, H.-H., & Xu, Y.-Y. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9966-y · Cited by 81
Aging, Tolerance to High Altitude, and Cardiorespiratory Response to Hypoxia
Richalet, J., & Lhuissier, F. (2015) · High Altitude Medicine & Biology · doi:10.1089/ham.2015.0030 · Cited by 80
Hypoxia-induced angiogenesis is delayed in aging mouse brain
Benderro, G. F., & LaManna, J. C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.016 · Cited by 80
Culbreth, M. E., & Aschner, M. (2018) · F1000Research · doi:10.12688/f1000research.15239.1 · Cited by 79
Sun, Y., Huang, J., Chen, Y., Shang, H., Zhang, W., Yu, J., He, L., Xing, C., & Zhuang, C. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104172 · Cited by 73 · cited 1×
“Activation of Nrf2, both pharmacologically (El-Ghaiesh et al., 2020; Joseph et al., 2020; Lin et al., 2020; Sun et al., 2020) and by administering constituents of medicinal plants (Ahmad et al.”
BackgroundQuintessential Risk Factors: Their Role in Promoting Cognitive Dysfunction and Alzheimer’s Disease
Daulatzai, M. A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0854-6 · Cited by 70
Li, X., Cui, X., Chen, Y., Wu, T., Xu, H., Yin, H., & Wu, Y. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00121 · Cited by 70
Mao, X. R., & Crowder, C. M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00922-10 · Cited by 68
Rapino, C., Bianchi, G., Giulio, C. D., Centurione, L., Cacchio, M., Antonucci, A. T., & Cataldi, A. (2005) · Aging Cell · doi:10.1111/j.1474-9726.2005.00161.x · Cited by 67
Zhang, X., Li, L., Zhang, X., Xie, W., Li, L., Yang, D., Heng, X., Du, Y., Doody, R. S., & Le, W. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.012 · Cited by 66
Mechanisms of Memory Dysfunction during High Altitude Hypoxia Training in Military Aircrew
Nation, D. A., Bondi, M. W., Gayles, E., & Delis, D. C. (2016) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716000965 · Cited by 65
Protective Effects of Intermittent Hypoxic Adaptation on Myocardium and Its Mechanisms
Zhuang, J., & Zhou, Z.-N. (1999) · Neurosignals · doi:10.1159/000014602 · Cited by 64
White matter hyperintensities on MRI in high-altitude U-2 pilots
McGuire, S., Sherman, P. M., Profenna, L., Grogan, P. M., Sladky, J. H., Brown, A., Robinson, A. Y., Rowland, L. M., Hong, E. L., Patel, B., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a1ab12 · Cited by 64
Mateika, J. H., & Komnenov, D. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.011 · Cited by 64
Intermittent hypoxia caused cognitive dysfunction relate to miRNAs dysregulation in hippocampus
Gao, H., Han, Z., HUANG, S. H., Bai, R., Ge, X., Chen, F., & Lei, P. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.06.025 · Cited by 64
Regional cerebral blood flow alterations in obstructive sleep apnea
Yadav, S. K., Kumar, R., Macey, P. M., Richardson, H. L., Wang, D. J. J., Woo, M. A., & Harper, R. M. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.033 · Cited by 62
Glazachev, O. S., Kopylov, P., Susta, D., Dudnik, E. N., & Zagaynaya, E. (2017) · Clinical Cardiology · doi:10.1002/clc.22670 · Cited by 62
Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin
Zakharova, E. T., Av, S., Павличенко, Н. Н., Kostevich, V. A., Abdurasulova, I. N., Владимирович, Ч. А., Voynova, I. V., Elizarova, A. Y., Kolmakov, N. N., Bass, M. G., et al. (2018) · BioMetals · doi:10.1007/s10534-018-0111-9 · Cited by 62
Kaushal, N., Ramesh, V., & Gozal, D. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00025.2012 · Cited by 61
Diagnosis and Management in Dementia
(2020) · Elsevier eBooks · doi:10.1016/c2017-0-03213-5 · Cited by 61
Kim, K. S., Kwak, J. W., Lim, S. J., Park, Y. K., Yang, H. S., & Kim, H. J. (2016) · Aging and Disease · doi:10.14336/ad.2016.0215 · Cited by 60
Dreyer, J. B. B., Higuchi, P., & da Silva, A. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-40531-8 · Cited by 60
Intermittent hypoxia improves cognition and reduces anxiety‐related behavior in APP/PS1 mice
Meng, S., Wang, B., & Li, W. (2019) · Brain and Behavior · doi:10.1002/brb3.1513 · Cited by 58
Verbal Free Recall in High Altitude: Proper Names vs Common Names
Pelamatti, G., Pascotto, M., & Semenza, C. (2003) · Cortex · doi:10.1016/s0010-9452(08)70077-7 · Cited by 56
Melatonin reduces hippocampal β-amyloid generation in rats exposed to chronic intermittent hypoxia
Ng, K., Lau, C. G., & Fung, M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.044 · Cited by 55
Hypoxia Conditioning as a Promising Therapeutic Target in Parkinson's Disease?
Burtscher, J., Syed, M. M. K., Lashuel, H. A., & Millet, G. P. (2021) · Movement Disorders · doi:10.1002/mds.28544 · Cited by 55
Self-citationYang, T., & Zhang, F. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314804 · Cited by 53
Kerridge, C., Kozlova, D. I., Nalivaeva, N. N., & Turner, A. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00426 · Cited by 52
Ahmad, R., Khan, A., Lee, H. J., Rehman, I. U., Khan, I., Alam, S. I., & Kim, M. O. (2020) · Biomedicines · doi:10.3390/biomedicines8100380 · Cited by 50
Biswal, S., Sharma, D., Kumar, K., Nag, T. C., Barhwal, K. K., Hota, S. K., & Kumar, B. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.05.011 · Cited by 49
Lin, C., Wei, P., Chen, C., Huang, Y., Lin, J.-L., Lo, Y., Lin, J.-L., Lin, C., Wu, Y., Chang, K., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00226 · Cited by 49
Chen, T., Li, J., Chao, D., Sandhu, H. K., Liao, X., Zhao, J., Wen, G., & Xia, Y. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.02.022 · Cited by 48
Richardson, C., Hogan, A. M., Bucks, R. S., Bayá, A., Ortega, J. V., Holloway, J. W., Rose-Zerilli, M. J. J., Palmer, L. J., Webster, R. J., Kirkham, F. J., et al. (2011) · Clinical Neurophysiology · doi:10.1016/j.clinph.2011.02.001 · Cited by 48
Mahan, S., Rous, R. S., & Adlam, A. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716001065 · Cited by 48
Exercise Performance of Lowlanders with COPD at 2,590 m: Data from a Randomized Trial
Furian, M., Hartmann, S. E., Latshang, T. D., Flueck, D., Murer, C., Scheiwiller, P. M., Osmonov, B., Ulrich, S., Kohler, M., Poulin, M. J., et al. (2018) · Respiration · doi:10.1159/000486450 · Cited by 48
Carotid chemoreceptor “resetting” revisited
Carroll, J. L., & Kim, I. (2012) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2012.09.002 · Cited by 47
Is there a molecular connection between hypoxia and aging?
Katschinski, D. M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2005.12.003 · Cited by 47
Lim, K. H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00158 · Cited by 47
Hypoxic–hyperoxic conditioning and dementia
Mallet, R. T., Burtscher, J., Manukhina, E. B., Downey, H. F., Glazachev, O. S., Serebrovskaya, T. V., & Burtscher, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00047-1 · Cited by 47
Self-citationProduction and Storage of Nitric Oxide in Adaptation to Hypoxia
Manukhina, E. B., Malyshev, I. Y., Smirin, B. V., Mashina, S. Y., Saltykova, V. A., & Vanin, A. F. (1999) · Nitric Oxide · doi:10.1006/niox.1999.0244 · Cited by 46
Cited by
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
Inoue, Y., Shue, F., Bu, G., & Kanekiyo, T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00640-5 · Cited by 329
Mitochondria: It is all about energy
Casanova, A., Wevers, A., Navarro-Ledesma, S., & Pruimboom, L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1114231 · Cited by 303
Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg?
Tamagno, E., Guglielmotto, M., Vasciaveo, V., & Tabaton, M. (2021) · Antioxidants · doi:10.3390/antiox10091479 · Cited by 264
Impact of skin tone on photoacoustic oximetry and tools to minimize bias
Mantri, Y., & Jokerst, J. V. (2022) · Biomedical Optics Express · doi:10.1364/boe.450224 · Cited by 75
Metadata
- Authors
- Burtscher, J., Mallet, R. T., Burtscher, M., & Millet, G. P.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 68
- Pages
- 101343
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W3153612365
- Cited by
- 324
- References
- 273
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.